303 related articles for article (PubMed ID: 37336067)
1. Exploring N-myristoyltransferase as a promising drug target against parasitic neglected tropical diseases.
Nascimento IJDS; Cavalcanti MAT; de Moura RO
Eur J Med Chem; 2023 Oct; 258():115550. PubMed ID: 37336067
[TBL] [Abstract][Full Text] [Related]
2. Flavonoids as efficient scaffolds: Recent trends for malaria, leishmaniasis, Chagas disease, and dengue.
Boniface PK; Ferreira EI
Phytother Res; 2019 Oct; 33(10):2473-2517. PubMed ID: 31441148
[TBL] [Abstract][Full Text] [Related]
3. Small molecules containing chalcogen elements (S, Se, Te) as new warhead to fight neglected tropical diseases.
Henriquez-Figuereo A; Morán-Serradilla C; Angulo-Elizari E; Sanmartín C; Plano D
Eur J Med Chem; 2023 Jan; 246():115002. PubMed ID: 36493616
[TBL] [Abstract][Full Text] [Related]
4. Dual Inhibition of Parasitic Targets: A Valuable Strategy to Treat Malaria and Neglected Tropical Diseases.
Previti S; Di Chio C; Ettari R; Zappalà M
Curr Med Chem; 2022; 29(17):2952-2978. PubMed ID: 34375176
[TBL] [Abstract][Full Text] [Related]
5. Validation of N-myristoyltransferase as Potential Chemotherapeutic Target in Mammal-Dwelling Stages of Trypanosoma cruzi.
Herrera LJ; Brand S; Santos A; Nohara LL; Harrison J; Norcross NR; Thompson S; Smith V; Lema C; Varela-Ramirez A; Gilbert IH; Almeida IC; Maldonado RA
PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004540. PubMed ID: 27128971
[TBL] [Abstract][Full Text] [Related]
6. Galectins in Protozoan Parasitic Diseases: Potential Applications in Diagnostics and Therapeutics.
Meira C; Silva J; Quadros H; Silva L; Barreto B; Rocha V; Bomfim L; Santos E; Soares M
Cells; 2023 Nov; 12(23):. PubMed ID: 38067100
[TBL] [Abstract][Full Text] [Related]
7. Aminoacyl-tRNA synthetase (AARS) as an attractive drug target in neglected tropical trypanosomatid diseases-Leishmaniasis, Human African Trypanosomiasis and Chagas disease.
Kushwaha V; Capalash N
Mol Biochem Parasitol; 2022 Sep; 251():111510. PubMed ID: 35988745
[TBL] [Abstract][Full Text] [Related]
8. Potentials of marine natural products against malaria, leishmaniasis, and trypanosomiasis parasites: a review of recent articles.
Nweze JA; Mbaoji FN; Li YM; Yang LY; Huang SS; Chigor VN; Eze EA; Pan LX; Zhang T; Yang DF
Infect Dis Poverty; 2021 Jan; 10(1):9. PubMed ID: 33482912
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Potential of Flavonoid Derivatives for Certain Neglected Tropical Diseases.
Pone BK; Ferreira EI
Curr Drug Targets; 2022; 23(7):680-682. PubMed ID: 35264087
[TBL] [Abstract][Full Text] [Related]
10. Metallodrugs for the Treatment of Trypanosomatid Diseases: Recent Advances and New Insights.
Navarro M; Justo RMS; Delgado GYS; Visbal G
Curr Pharm Des; 2021; 27(15):1763-1789. PubMed ID: 33185155
[TBL] [Abstract][Full Text] [Related]
11. Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria.
Álvarez-Bardón M; Pérez-Pertejo Y; Ordóñez C; Sepúlveda-Crespo D; Carballeira NM; Tekwani BL; Murugesan S; Martinez-Valladares M; García-Estrada C; Reguera RM; Balaña-Fouce R
Mar Drugs; 2020 Mar; 18(4):. PubMed ID: 32244488
[TBL] [Abstract][Full Text] [Related]
12. Recent Theoretical Studies Concerning Important Tropical Infections.
Scotti MT; Monteiro AFM; de Oliveira Viana J; Bezerra Mendonça Junior FJ; Ishiki HM; Tchouboun EN; De Araújo RSA; Scotti L
Curr Med Chem; 2020; 27(5):795-834. PubMed ID: 31296154
[TBL] [Abstract][Full Text] [Related]
13. Exploring the Potential of Natural Products as Antiparasitic Agents for Neglected Tropical Diseases.
Orosco D; Mendoza AR; Meléndez CM
Curr Top Med Chem; 2024; 24(2):89-108. PubMed ID: 37842892
[TBL] [Abstract][Full Text] [Related]
14. Drug discovery in leishmaniasis using protein lipidation as a target.
Brannigan JA; Wilkinson AJ
Biophys Rev; 2021 Dec; 13(6):1139-1146. PubMed ID: 35035594
[TBL] [Abstract][Full Text] [Related]
15. Search for Antiprotozoal Activity in Herbal Medicinal Preparations; New Natural Leads against Neglected Tropical Diseases.
Llurba Montesino N; Kaiser M; Brun R; Schmidt TJ
Molecules; 2015 Aug; 20(8):14118-38. PubMed ID: 26248069
[TBL] [Abstract][Full Text] [Related]
16. Drug discovery for the treatment of leishmaniasis, African sleeping sickness and Chagas disease.
Future Med Chem; 2013 Oct; 5(15):1709-18. PubMed ID: 24144408
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. N-Myristoyltransferase as a potential drug target in malaria and leishmaniasis.
Tate EW; Bell AS; Rackham MD; Wright MH
Parasitology; 2014 Jan; 141(1):37-49. PubMed ID: 23611109
[TBL] [Abstract][Full Text] [Related]
19. Systematic study of 1,2,3-triazolyl sterols for the development of new drugs against parasitic Neglected Tropical Diseases.
Porta EOJ; Ballari MS; Carlucci R; Wilkinson S; Ma G; Tekwani BL; Labadie GR
Eur J Med Chem; 2023 Jun; 254():115378. PubMed ID: 37084599
[TBL] [Abstract][Full Text] [Related]
20. Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning.
Kaiser M; Mäser P; Tadoori LP; Ioset JR; Brun R
PLoS One; 2015; 10(8):e0135556. PubMed ID: 26270335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
